EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epigenetic Markers of Cell Division and Ageing in Relation to Breast Cancer Survival

Luca Li, Elaheh Zarean, Danmeng Lily Li, Yiyue Zhu, Shuai Li iD, Enes Makalic, Catriona McLean, Graham G Giles, Roger L Milne, Melissa C Southey, Pierre-Antoine Dugué iD

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Luca Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: Breast Neoplasms, DNA Methylation, Epigenesis, Genetic, Cell Division. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victoria Cancer Agency Mid-Career Fellowship, VicHealth, Cancer Council Victoria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer remains a major challenge to public health. Biomarkers may be useful to improve prediction of breast cancer survival. Several epigenetic markers of cell division and ageing based on DNA methylation have been proposed. In this study, we measured these epigenetic markers in breast tumours and assessed their prognostic value. We used genome‐wide DNA methylation data measured in 1992 breast cancer tumours from the Melbourne Collaborative Cohort Study and publicly available datasets. We calculated four markers of cell division ( epiTOC2 , stemTOC , MiAge and CellDRIFT ), two markers of chronological age ( Horvath age and BTEC ), and four markers of biological age ( PhenoAge , GrimAge , MRscore and DunedinPACE ). Cox regression models were used to assess the associations of age‐adjusted epigenetic markers with 5‐year overall survival, with adjustment for clinical variables. Effect modification by estrogen receptor (ER) status and molecular subtype was also investigated. After adjustment for age and stratification by study, higher levels of cell division markers were associated with poorer survival (e.g., epiTOC2 : per one‐standard‐deviation increase, hazard ratio [HR] = 1.14, 95% CI: 1.03–1.27), whereas higher chronological age markers were linked to better prognosis (e.g., Horvath age : HR = 0.70, 95% CI: 0.61–0.82). Epigenetic markers of biological age showed variable associations. These associations were partly explained by the main clinicopathological variables at diagnosis and varied across subtypes. Our study revealed associations of several epigenetic markers with breast cancer survival. The associations were quite weak, suggesting these markers may have limited prognostic value. The varying associations observed among subtypes may reflect underlying biological differences that should be further investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDNA MethylationEpigenesis, GeneticCell DivisionBiomarkers, TumorAgingHumansFemalePrognosisMiddle AgedAgedAdult

Stichwörter der Autor:innen

DNA methylationageingbreast cancercancer survivalepigenetics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Department of Data Science and AI, Faculty of Information Technology, Monash University, Clayton, Victoria, Australia.
  • Anatomical Pathology, Alfred Health, The Alfred Hospital, Melbourne, Victoria, Australia.
  • Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.

ORCID-Profile: Shuai Li, Pierre-Antoine Dugué

Förderung

  • Victoria Cancer Agency Mid-Career Fellowship
  • VicHealth
  • Cancer Council Victoria
  • Wellcome Trust
  • National Health and Medical Research Council (NHMRC)
  • NHMRC L3 Investigator Fellowship
  • NHMRC EL1 Investigator Fellowship
  • Monash University PhD scholarship

Zitieren

APA

Li, L., Zarean, E., Li, D. L., Zhu, Y., Li, S., Makalic, E., McLean, C., Giles, G. G., Milne, R. L., Southey, M. C., & Dugué, P. A. (2026). Epigenetic Markers of Cell Division and Ageing in Relation to Breast Cancer Survival. International Journal of Cancer. https://doi.org/10.1002/ijc.70618

Vancouver

Li L, Zarean E, Li DL, Zhu Y, Li S, Makalic E, et al. Epigenetic Markers of Cell Division and Ageing in Relation to Breast Cancer Survival. International Journal of Cancer. 2026. doi:10.1002/ijc.70618

BibTeX
@article{Li2026,
  author = {Li, Luca and Zarean, Elaheh and Li, Danmeng Lily and Zhu, Yiyue and Li, Shuai and Makalic, Enes and McLean, Catriona and Giles, Graham G and Milne, Roger L and Southey, Melissa C and Dugué, Pierre-Antoine},
  title = {Epigenetic Markers of Cell Division and Ageing in Relation to Breast Cancer Survival},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70618}
}
Kostenlos starten →